Shenghan Lai1, Elliot K Fishman, Hong Lai, Richard Moore, Joseph Cofrancesco, Harpreet Pannu2, Wenjing Tong, Jiefu Du, John Barlett. 1. Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland. slai@jhmi.edu 2. Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. slai@jhmi.edu
Abstract
BACKGROUND: Long-term use of cocaine (⩾15 years) and antiretroviral therapy (ART) have been implicated in cardiovascular complications. Nevertheless, the individual and combined effects of ART and cocaine use on silent coronary artery disease have not been fully investigated. Methods: Computed tomography coronary angiography was performed for 165 human immunodeficiency virus (HIV)– infected African American study participants aged 25–54 years in Baltimore, Maryland, with contrast-enhanced 64-slice multidetector computed tomography imaging.Result: Significant (⩾50%) coronary stenosis was detected in 24 (15%) of 165 participants. The prevalence of significant stenosis among those who had used cocaine for ⩾15 years and had received ART for ⩾6 months was 42%. Exact logistic regression analysis revealed that long-term cocaine use(adjusted odds ratio, 7.75; 95% confidence interval, 2.26–31.2) and exposure to ART for ⩾6 months(adjusted odds ratio, 4.35; 95% confidence interval, 1.30–16.4) were independently associated with the presence of significant coronary stenosis. In addition, after controlling for confounding factors,both stavudine use for ⩾6 months or combivir use for ⩾6 months were independently associated with the presence of significant coronary stenosis.Conclusions: Long-term exposure to ART may be associated with silent coronary artery disease;however, the magnitude of increased risk associated with ART was much lower than the risk associated with cocaine use or traditional risk factors. Cardiovascular monitoring and aggressive modification of cardiovascular risk factors are essential for reducing the risk of coronary artery disease in HIV-infected individuals. Extensive efforts should also be made to develop effective cocaine use cessation programs for HIV-infected cocaine users.
BACKGROUND: Long-term use of cocaine (⩾15 years) and antiretroviral therapy (ART) have been implicated in cardiovascular complications. Nevertheless, the individual and combined effects of ART and cocaine use on silent coronary artery disease have not been fully investigated. Methods: Computed tomography coronary angiography was performed for 165 human immunodeficiency virus (HIV)– infected African American study participants aged 25–54 years in Baltimore, Maryland, with contrast-enhanced 64-slice multidetector computed tomography imaging.Result: Significant (⩾50%) coronary stenosis was detected in 24 (15%) of 165 participants. The prevalence of significant stenosis among those who had used cocaine for ⩾15 years and had received ART for ⩾6 months was 42%. Exact logistic regression analysis revealed that long-term cocaine use(adjusted odds ratio, 7.75; 95% confidence interval, 2.26–31.2) and exposure to ART for ⩾6 months(adjusted odds ratio, 4.35; 95% confidence interval, 1.30–16.4) were independently associated with the presence of significant coronary stenosis. In addition, after controlling for confounding factors,both stavudine use for ⩾6 months or combivir use for ⩾6 months were independently associated with the presence of significant coronary stenosis.Conclusions: Long-term exposure to ART may be associated with silent coronary artery disease;however, the magnitude of increased risk associated with ART was much lower than the risk associated with cocaine use or traditional risk factors. Cardiovascular monitoring and aggressive modification of cardiovascular risk factors are essential for reducing the risk of coronary artery disease in HIV-infected individuals. Extensive efforts should also be made to develop effective cocaine use cessation programs for HIV-infectedcocaine users.
Authors: Alexander W Leber; Andreas Knez; Franz von Ziegler; Alexander Becker; Konstantin Nikolaou; Stephan Paul; Bernd Wintersperger; Maximilian Reiser; Christoph R Becker; Gerhard Steinbeck; Peter Boekstegers Journal: J Am Coll Cardiol Date: 2005-07-05 Impact factor: 24.094
Authors: R H Haubrich; S J Little; J S Currier; D N Forthal; C A Kemper; G N Beall; D Johnson; M P Dubé; J Y Hwang; J A McCutchan Journal: AIDS Date: 1999-06-18 Impact factor: 4.177
Authors: Shenghan Lai; Joao A C Lima; Hong Lai; David Vlahov; David Celentano; Wenjing Tong; John G Bartlett; Joseph Margolick; Elliot K Fishman Journal: Arch Intern Med Date: 2005-03-28
Authors: R Walli; O Herfort; G M Michl; T Demant; H Jäger; C Dieterle; J R Bogner; R Landgraf; F D Goebel Journal: AIDS Date: 1998-10-22 Impact factor: 4.177
Authors: Hong Lai; Gary Gerstenblith; Elliot K Fishman; Jeffrey Brinker; Thomas Kickler; Wenjing Tong; Sundeepan Bhatia; Tai Hong; Shaoguang Chen; Ji Li; Barbara Detrick; Shenghan Lai Journal: Clin Infect Dis Date: 2012-03-15 Impact factor: 9.079
Authors: Veit Sandfort; David A Bluemke; Jose Vargas; Jeffrey A Brinker; Gary Gerstenblith; Thomas Kickler; Gang Zheng; Ji Li; Shaoguang Chen; Hong Lai; Elliot K Fishman; Shenghan Lai Journal: J Addict Med Date: 2017 Mar/Apr Impact factor: 3.702
Authors: Raza M Alvi; Maryam Afshar; Anne M Neilan; Noor Tariq; Malek Hassan; Jaime Gerber; Magid Awadalla; Connor P Mulligan; Adam Rokicki; Virginia A Triant; Markella V Zanni; Tomas G Neilan Journal: Am Heart J Date: 2019-01-11 Impact factor: 4.749
Authors: Sara E Looby; Kathleen V Fitch; Suman Srinivasa; Janet Lo; Danielle Rafferty; Amanda Martin; Judith C Currier; Steven Grinspoon; Markella V Zanni Journal: AIDS Date: 2016-01-28 Impact factor: 4.177
Authors: Gregory M Lucas; Yuezhou Jing; Mark Sulkowski; Alison G Abraham; Michelle M Estrella; Mohamed G Atta; Derek M Fine; Marina B Klein; Michael J Silverberg; M John Gill; Richard D Moore; Kelly A Gebo; Timothy R Sterling; Adeel A Butt Journal: J Infect Dis Date: 2013-07-31 Impact factor: 5.226
Authors: Hong Lai; Elliot K Fishman; Gary Gerstenblith; Jeffrey A Brinker; Wenjing Tong; Sandeepan Bhatia; Barbara Detrick; Shenghan Lai Journal: Int J Cardiol Date: 2011-02-03 Impact factor: 4.164
Authors: Gregory M Lucas; Mohamed G Atta; Derek M Fine; Allison M McFall; Michelle M Estrella; Katie Zook; James H Stein Journal: Arterioscler Thromb Vasc Biol Date: 2016-09-08 Impact factor: 8.311